Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Laxxon Medical Corp., a leading pharma technology platform company focusing on oral drug...
top of page
Laxxon Medical
Oct 143 min read
Laxxon Medical to Present Innovative Oral GLP-1 Agonist including Multi-Compartment Micro-Tablet Form at 2024 BIO-Europe Convention, Aiming to Enhance Compliance for Special Patient Groups
Laxxon is seeking out-licensing opportunities for lead asset LXM.2, or co-developments projects with 3DSP platform technology SPID® at...
Laxxon Medical
Oct 92 min read
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical , a US-based pharma-technology company pioneering a new generation of...
Laxxon Medical
Oct 23 min read
Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP fa
Laxxon Medical
May 222 min read
Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Learn more about Laxxon Medical's groundbreaking 3D printed oral GLP-1 asset, offering an alternative to injections in obesity treatments.
Laxxon Medical
May 162 min read
Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024
Laxxon Medical announced its participation in the 2024 BIO International Convention, to showcase its LXM.2 asset to potential partners.
Laxxon Medical
Apr 232 min read
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024
Join Dr.Catherine Gatza, our VP of Regulatory Affairs, at the World Orphan Drug Congress USA 2024, in Boston, Massachusetts.
Laxxon Medical
Mar 281 min read
Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference
Laxxon Medical, a pioneering pharma-technology company, is set to participate in the 23rd Annual Needham Virtual Health Conference.
Laxxon Medical
Mar 252 min read
Laxxon Medical Granted U.S. Patent for the Sequential Release of Multiple Drugs Within Pharmaceutical Dosage Forms
Discover how Laxxon Medical's patent for the sequential release of multiple drugs in pharmaceutical dosage forms revolutionizes healthcare.
Laxxon Medical
Dec 18, 20231 min read
Laxxon Medical to Participate in 26th Annual Needham Growth Conference
Discover the groundbreaking pharmaceutical advancements of Laxxon Medical at the 26th Annual Needham Growth Conference.
Laxxon Medical
Dec 6, 20231 min read
Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
Laxxon Medical announced its attending the 42nd Annual J.P. Morgan Healthcare Conference, the industry's largest healthcare symposium.
Laxxon Medical
Nov 16, 20233 min read
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company's inaugural globalization venture.
Laxxon Medical
Nov 6, 20232 min read
Laxxon Medical to Attend BIO-Europe Munich 2023
Laxxon Medical announced its participation in the 29th annual BIO-Europe Convention, taking place November 6-8, 2023, in Munich, Germany.
Laxxon Medical
Jul 18, 20233 min read
Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic Partnership
Laxxon Medical announced today their strategic partnership with CU Innovations at the University of Colorado Anschutz Medical Campus.
Laxxon Medical
Jul 3, 20233 min read
3D Screen Printing Technology Enables Fabrication of Oral Drug Dosage Forms
Quick Response (QR) codes have shown enormous potential to improve the flow of information from industry to providers and patients by...
Laxxon Medical
Jun 1, 20231 min read
Laxxon Medical to Participate in 2023 BIO International Convention
Laxxon Medical to Participate in 2023 BIO International Convention
Laxxon Medical
May 31, 20235 min read
Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts
Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts
Laxxon Medical
May 1, 20234 min read
Laxxon Medical's Commitment to Meeting and Exceeding CGMP Regulations In 3D Printed Pharmaceuticals
Hovione and Laxxon Medical have partnered for the cGMP production of 3D Screen Printed pharmaceutical applications.
Laxxon Medical
Apr 6, 20232 min read
CSO Achim Schneeberger Discusses the Development of Laxxon's Levodopa Project
CSO Achim Schneeberger speaks on the development of Laxxon's Levodopa project and the process of Laxxon's technology.
Laxxon Medical
Mar 28, 20234 min read
Interview with Laxxon COO Klaus Kuehne
Exploring Patient Safety, Compliance & 3D Screen Printing with Laxxon COO Klaus Kühne
bottom of page